Suppr超能文献

EeCentrocin 1 衍生肽 EC1-17KV 通过破坏细胞膜的方式表现出抗菌和抗生物膜活性。

Antimicrobial and antibiofilm activity of the EeCentrocin 1 derived peptide EC1-17KV via membrane disruption.

机构信息

School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu 211198, China.

Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & the Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, China.

出版信息

EBioMedicine. 2020 May;55:102775. doi: 10.1016/j.ebiom.2020.102775. Epub 2020 May 11.

Abstract

BACKGROUND

The antibiotic resistance and biofilm formation of pathogenic microbes exacerbate the difficulties of anti-infection therapy in the clinic. The structural modification of antimicrobial peptides (AMP) is an effective strategy to develop novel anti-infective agents.

METHOD

Seventeen amino acids (AA) in the longer chain of EeCentrocin 1 (from the edible sea-urchin Echinus esculentus) were truncated and underwent further modification. To produce lead peptides with low toxicity and high efficacy, the antimicrobial activity or cytotoxicity of peptides was evaluated against various multidrug-resistant bacteria/fungi or mammalian cells in vivo/ in vitro. In addition, the stability and modes of action of the lead peptide were investigated.

FINDINGS

EC1-17KV displayed potent activity and an expanded antimicrobial spectrum, especially against drug-resistant gram-negative bacteria and fungi, attributable to its enhanced amphiphilicity and net charge. In addition, it exhibits bactericidal/fungicidal activity and effectively increased the animal survival rate and mitigated the histopathological damage induced by multidrug-resistant P. aeruginosa or C. albicans in infected mice or G. mellonella. Moreover, EC1-17KV had a poor ability to induce resistance in bacteria and fungi and exhibited desirable high-salt/high-temperature tolerance properties. In bacteria, EC1-17KV promoted divalent cation release to damage bacterial membrane integrity. In fungi, it changed C. albicans membrane fluidity to increase membrane permeabilization or reduced hyphal formation to suppress biofilm formation.

INTERPRETATION

EC1-17KV is a promising lead peptide for the development of antimicrobial agents against antibiotic resistant bacteria and fungi.

FUNDING

This work was funded by the National Natural Science Foundation of China (No. 81673483, 81803591); National Science and Technology Major Project Foundation of China (2019ZX09721001-004-005); National Key Research and Development Program of China (2018YFA0902000); "Double First-Class" University project (CPU2018GF/GY16); Natural Science Foundation of Jiangsu Province of China (No. BK20180563); and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.

摘要

背景

病原菌的抗生素耐药性和生物膜形成加剧了临床抗感染治疗的困难。抗菌肽(AMP)的结构修饰是开发新型抗感染药物的有效策略。

方法

从可食用的海胆(Echinus esculentus)中切去长链的 EeCentrocin 1 的 17 个氨基酸(AA),并进一步修饰。为了生产具有低毒性和高效的先导肽,在体内/体外评估了肽对各种多药耐药菌/真菌或哺乳动物细胞的抗菌活性或细胞毒性。此外,还研究了先导肽的稳定性和作用模式。

结果

EC1-17KV 表现出强大的活性和广谱的抗菌谱,特别是对耐药革兰氏阴性菌和真菌,这归因于其增强的两亲性和亲电性。此外,它具有杀菌/杀真菌活性,有效提高了动物的存活率,并减轻了多药耐药铜绿假单胞菌或白色念珠菌感染小鼠或金龟子幼虫引起的组织病理学损伤。此外,EC1-17KV 诱导细菌和真菌产生耐药性的能力较差,表现出良好的耐高盐/高温特性。在细菌中,EC1-17KV 促进二价阳离子释放,破坏细菌膜完整性。在真菌中,它改变了白色念珠菌膜的流动性,增加了膜通透性,或减少了菌丝形成,从而抑制了生物膜的形成。

解释

EC1-17KV 是一种有前途的开发抗抗生素耐药细菌和真菌的抗菌肽先导肽。

资金

本工作得到国家自然科学基金(No. 81673483,81803591);国家科技重大专项基金(2019ZX09721001-004-005);国家重点研发计划(2018YFA0902000);“双一流”大学项目(CPU2018GF/GY16);江苏省自然科学基金(No. BK20180563);江苏省高校优势学科建设工程资助项目。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e398/7218270/9ac795628f9b/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验